Valeant (VRX): Pearson Recently Exercised Options, Required to Hold 1M Shares for 2 Years
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Valeant (VRX) Investors Should Be Focused on Earnings Not Upcoming Product Catalysts - Wells Fargo
July 14, 2016 1:29 PM EDTWhile Valeant Pharmaceuticals (NYSE: VRX) continues to avoid trading on fundamentals three potential catalysts lie ahead for the company. Today, Wells Fargo bearish-leaning analyst David Maris provide his thoughts ahead of these events.
The 3 events are:
Friday (7/15) advisory panel documents should become available ahead of next Tuesdays (7/19) FDA advisory panel on brodalumab;next... MoreValeant Pharma (VRX) Shares Rise After Clarifying Recent Pearson Stock, Options Sales
July 14, 2016 9:00 AM EDTValeant Pharma (NYSE: VRX) shares are indicated higher in early trading Thursday after the company issued commentary on recent stock transactions conducted by former CEO Mike Pearson. The stock is up over 3 percent.
... MoreHave Valeant Pharma (VRX) Shareholders Finally Capitulated?
July 13, 2016 12:24 PM EDTValeant Pharma (NYSE: VRX) is gaining as earlier reported liquidation at Sequoia Fund and news that ex-CEO... More
Valeant Pharma (VRX) Pearson Said to Have Sold 5M Shares - CNBC
July 13, 2016 11:28 AM EDTCNBC Scott Wapner reports Valeant Pharma (NYSE: VRX) Pearson unloaded much more of his holdings than originally thought. Nearly 5m shares and in the money options worth $96.8m.
... More
